Abstract
The Health Insurance Portability and Accountability Act (HIPPA) has been fully implemented in clinical practice and research settings. Although subject confidentiality has always been a concern, clinical researchers must now take extra care to attend to the mandates of privacy while also minding good clinical practice guidelines. Unanticipated conflicts may arise as a result of these dual priorities. This article presents two examples of potential challenges to confidentiality with comment from the bioethical perspective.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
